Pharmafile Logo
Pharmafocus logo
Advanced Search

Regeneron to invest $70m in NYC manufacturing

November 15, 2012
Manufacturing and Production NY, Regeneron, Sanofi, US

Regeneron has confirmed it will invest almost $70 million to expand its manufacturing in New York City in a move …

News
Jeremy Hunt image

Hunt: England to be technology ‘leader’

November 15, 2012
Medical Communications, Sales and Marketing Jeremy Hunt, NHS, telehealth

Technology is to free 100,000 people next year from what health secretary Jeremy Hunt calls the ‘constant merry-go-round’ of doctors’ …

News
Lundbeck plant image

Lundbeck opens first Asian manufacturing plant

November 14, 2012
Manufacturing and Production China, Lundbeck

Lundbeck has officially opened its first manufacturing facility in China and says it plans to launch three new drugs there …

News

Germany dismisses Seroquel XR

November 14, 2012
Sales and Marketing AstraZeneca, FDA, Germany, Seroquel XR

AstraZeneca has received another dent in its international attempts to keep the money-spinning antipsychotic Seroquel going in a new form. …

News

No specific targets in NHS mandate

November 14, 2012
Sales and Marketing CCGs, NHS, commissioning

The government has given the first public directive to the nascent NHS Commissioning Board, which assumes its new responsibilities from …

News
eugene_washington-iha-005108

Eugene Washington appointed to J&J Board of directors

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Eugene Washington, J&J, JJ

Dr Eugene Washington has been appointed to the Board of directors at Johnson & Johnson. Washington serves as vice chancellor …

Appointment

AstraZeneca signs genome deal

November 13, 2012
Research and Development, Sales and Marketing AstraZeneca, Foundation, SMIP

AstraZeneca has signed a genomic profiling agreement with US molecular information company Foundation Medicine. The collaboration will use its FoundationOne …

News

EFCG calls for mandatory inspection of API plants

November 13, 2012
Manufacturing and Production API, EFCG, EU, FMD

The European Fine Chemicals Group (EFCG) has called for all active pharmaceutical ingredient (API) manufacturing facilities to undergo mandatory inspections. …

News
Hospira image

Hospira on track to return propofol to market

November 13, 2012
Manufacturing and Production Ball, Hospira, Teva

Shortages of the short-acting anaesthetic propofol in the US could be helped by the return to market of a generic …

News
coulthard

NHS Commissioning Board appoints Patients and Information directors

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Coulthard, NHS, NHS Commissioning Board

The NHS Commissioning Board has made a series of appointments to complete its director-level recruitment to the Patients & Information …

Appointment
kb

Pharma can help NHS transition, says partnership leader

November 13, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, CCGs, Conference, NHS, PCT

A new ABPI team is now ready to help the pharmaceutical industry forge partnerships with the NHS, even as the …

Feature

Patients ‘shut out’ of drug price talks

November 13, 2012
Sales and Marketing Cancer, NHS, NICE, VBP, prostate

Patients are being excluded from the negotiations between government and the pharma industry on the introduction of Value-Based Pricing (VBP).That …

News
Pfizer image

Pfizer and GSK end agreements

November 12, 2012
Research and Development, Sales and Marketing Auxilium, GSK, Pfizer, Xenoport

Pfizer and GlaxoSmithKline are both handing back the rights to two drugs in April 2013 as part of the termination …

News

Havas Health launches new Global Agency Group, Havas Lynx

November 12, 2012
Medical Communications

 Euro RSCG Life 4D and Creative Lynx join to form new Global Brand for the next era in Health and …

News
Press release

Contract research news in brief

November 12, 2012
Research and Development Bay Bioanalytical Laboratory, Bioclinica, Charles River, ICON, Pacific BioLabs, Quintiles, Vital River

Acquisitions for Charles River and Pacific BioLabs, a new contract for Bioclinica plus updates from Icon and Quintiles.

News
board_peter_chambre

immatics appoints Peter Chambré as chairman

November 12, 2012
Manufacturing and Production, Research and Development, Sales and Marketing Peter Chambre, immatics

Biotech development firm immatics has announced the appointment of Peter Chambré as chairman of the Board. Chambré has had extensive …

Appointment
NHS image

NHS: pharma needs to help more

November 12, 2012
Sales and Marketing CCGs, NHS, pharma

A variety of senior figures in public health set out how they want the pharma industry to do more to …

News
copper image

Copper could replace precious metals in pharma production

November 9, 2012
Manufacturing and Production Sweden, copper, manufacturing

Non-precious metals such as copper could be used as catalysts in pharmaceuticals production, replacing precious metals that are expensive and …

News
Revolade image

GSK guilty of off-label promotion

November 9, 2012
Medical Communications, Sales and Marketing GSK, PMCPA, Revolade

GlaxoSmithKline has been found to have breached three clauses in the ABPI Code of Practice following a complaint from a …

News
stephen whitehead image

Pharma treated as though ‘selling cyanide’

November 9, 2012
Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, NHS, Stephen Whitehead

APBI chief executive Stephen Whitehead claimed that pharma companies are sometimes made to feel as though they are manufacturing poison …

News
The Gateway to Local Adoption Series

Latest content

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026

Alvotech appoints Lisa Graver as CEO

February 3, 2026

HonorHealth Research Institute announces first patient dosed with new stroke treatment

February 2, 2026

Accord Healthcare appoints Paul Burden as Associate Vice President and Country Head UK

February 2, 2026

Historic UN declaration supporting mental health – treatment to be given similar priority to chronic diseases

January 30, 2026